Literature DB >> 15877730

Bone involvement in sickle cell disease.

Antonio Almeida1, Irene Roberts.   

Abstract

Bone involvement is the commonest clinical manifestation of sickle cell disease both in the acute setting such as painful vaso-occlusive crises, and as a source of chronic, progressive disability such as avascular necrosis. Management of these problems is often difficult because of the diagnostic imprecision of most laboratory and imaging investigations and because of the lack of evidence for most surgical procedures in sickle cell disease. This review first discusses the acute problems related to bone involvement in sickle cell disease, with particular reference to differentiating infection from infarction, and then describes the long-term effects of sickle cell disease on bone mineral density, growth, and chronic bone and joint damage.

Entities:  

Mesh:

Year:  2005        PMID: 15877730     DOI: 10.1111/j.1365-2141.2005.05476.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  76 in total

1.  Osteonecrosis and leg ulceration in Indian sickle cell patients.

Authors:  Sanjay Pandey; R M Mishra; Renu Saxena
Journal:  Indian J Pediatr       Date:  2011-12-29       Impact factor: 1.967

2.  Evaluation of panoramic radiomorphometric indices related to low bone density in sickle cell disease.

Authors:  F S Neves; L S A F Oliveira; M G G Torres; M B P Toralles; M C B O da Silva; M I G Campos; P S F Campos; I Crusoé-Rebello
Journal:  Osteoporos Int       Date:  2011-10-18       Impact factor: 4.507

3.  Unusual sites of Salmonella osteoarthritis in patients with sickle cell disease: two cases.

Authors:  C Bachmeyer; W Ammouri; P M'Bappé; L Combescure; F Lionnet; R Girot; G Grateau
Journal:  Clin Rheumatol       Date:  2006-08-29       Impact factor: 2.980

Review 4.  Influence of body weight on bone mass, architecture and turnover.

Authors:  Urszula T Iwaniec; Russell T Turner
Journal:  J Endocrinol       Date:  2016-06-27       Impact factor: 4.286

Review 5.  Zoledronic acid in pediatric metabolic bone disorders.

Authors:  Sasigarn A Bowden; John D Mahan
Journal:  Transl Pediatr       Date:  2017-10

Review 6.  Rheumatologic manifestations of benign and malignant haematological disorders.

Authors:  Vinod Ravindran; Parameswaran Anoop
Journal:  Clin Rheumatol       Date:  2011-06-23       Impact factor: 2.980

7.  Correlation between maxillofacial radiographic features and systemic severity as sickle cell disease severity predictor.

Authors:  Frederico Sampaio Neves; Cristina Pinho Passos; Christiano Oliveira-Santos; Maria Cristina Teixeira Cangussu; Paulo Sérgio Flores Campos; Roberto José Meyer Nascimento; Iêda Crusoé-Rebello; Maria Isabela Guimarães Campos
Journal:  Clin Oral Investig       Date:  2011-06-07       Impact factor: 3.573

Review 8.  When Low Bone Mineral Density and Fractures Is Not Osteoporosis.

Authors:  Smita Jha; Marquis Chapman; Kelly Roszko
Journal:  Curr Osteoporos Rep       Date:  2019-10       Impact factor: 5.096

9.  Deletion of ferroportin in murine myeloid cells increases iron accumulation and stimulates osteoclastogenesis in vitro and in vivo.

Authors:  Lei Wang; Bin Fang; Toshifumi Fujiwara; Kimberly Krager; Akshita Gorantla; Chaoyuan Li; Jian Q Feng; Michael L Jennings; Jian Zhou; Nukhet Aykin-Burns; Haibo Zhao
Journal:  J Biol Chem       Date:  2018-05-03       Impact factor: 5.157

10.  Idiopathic facial swelling secondary to sickle cell anaemia.

Authors:  Swapnil Moghe; Ajay Pillai; Kanishka Navin Guru; Preeti P Nair
Journal:  BMJ Case Rep       Date:  2012-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.